股总动脉病变经皮斑块旋切术的中期结果
这项回顾性单中心研究纳入49例(50条肢体)孤立性股总动脉粥样硬化病变患者,接受定向或旋转斑块旋切术。技术成功率达98.0%,1年和3年一期通畅率分别为95.6%和79.6%,30天主要并发症率为0.0%,结论认为该方法中期通畅持久,可作为高风险或手术不适合患者的可行替代。
要点
- 股总动脉孤立病变旋切技术成功率高,中期通畅率接近外科内膜剥脱术。
- 高危患者(55.1%慢性肢体威胁性缺血,73.5%重度钙化)30天主要并发症为0。
核心结论
- 股总动脉孤立病变行初次经皮斑块旋切术中期通畅持久,结果接近外科内膜剥脱术,同时微创且避免永久植入物。
- 该方法可考虑作为特定高风险或手术不适合患者的可行替代方案。
研究设计与样本
- 队列平均年龄71.9±6.9岁,55.1%表现为慢性肢体威胁性缺血,73.5%病变重度钙化(>50%周径)。
- 主要终点为一期通畅率,定义为免于≥50%再狭窄或靶病变血运重建(TLR),采用双功超声评估至5年。
主要发现
- 技术成功(残余狭窄<30%)达98.0%, bailout支架置入率6.1%。
- 踝肱指数从0.66±0.19改善至0.95±0.19(P<0.001)。
- 1年和3年一期通畅率分别为95.6%和79.6%,随访期间TLR发生率为20.0%。
- 3年总生存率和保肢率分别为90.3%和97.9%。
- 30天主要并发症率为0.0%,仅1例(2.0%)轻微穿刺点血肿保守处理,中位住院1天(IQR 1-2天)。
关键数值与推荐
- 技术成功定义为残余狭窄<30%,本队列为98.0%。
- 一期通畅定义免于≥50%再狭窄或TLR。
- 主要并发症指30天内发生的严重不良事件,本队列为0.0%。
临床怎么用
- 对于孤立性股总动脉粥样硬化病变,尤其是高风险或手术不适合患者,可考虑经皮斑块旋切术作为替代治疗。
- 术后采用双功超声随访监测再狭窄,本队列1年通畅率95.6%、3年79.6%。
- 该技术微创、住院时间短(中位1天),且避免永久植入物,适合高并发症风险患者。
局限性
- 回顾性单中心设计,样本量较小(49例患者、50条肢体)。
- 缺乏与外科内膜剥脱术或其他腔内治疗的直接对照。
- 随访至5年,但中期结果主要报告至3年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the mid-term clinical and angiographic outcomes of primary percutaneous atherectomy for isolated atherosclerotic lesions of the common femoral artery (CFA). METHODS: This retrospective, single-center study included 49 patients (50 limbs) who underwent directional or rotational atherectomy between January 2017 and December 2025. The cohort was elderly (mean age 71.9 ± 6.9 years) and high risk, with 55.1% presenting with chronic limb-threatening ischemia. Severe calcification (>50% circumference) was observed in 73.5% of lesions. The primary endpoint was primary patency, defined as freedom from ≥50% restenosis or target lesion revascularization (TLR), assessed by duplex ultrasound up to 5 years. RESULTS: Technical success (<30% residual stenosis) was achieved in 98.0%. Bailout stenting was required in 6.1%. The ankle-brachial index improved from 0.66 ± 0.19 to 0.95 ± 0.19 (P < 0.001). Primary patency rates were 95.6% and 79.6% at 1 and 3 years, respectively. TLR occurred in 20.0% of lesions during follow-up. Three-year overall survival and limb salvage rates were 90.3% and 97.9%, respectively. The 30-day major complication rate was 0.0%, with a single minor access-site hematoma (2.0%) managed conservatively. The median hospital stay was 1 day (IQR, 1-2 days). CONCLUSION: Primary percutaneous atherectomy for isolated CFA lesions demonstrates durable mid-term patency, with outcomes approaching those reported for surgical endarterectomy, while minimizing invasiveness and avoiding permanent implants. These findings suggest that this approach may be considered a feasible alternative in selected high-risk or surgically unsuitable patients.
引用
- Kim H, Cho S, Joh JH, et al. Mid-term Outcomes of Percutaneous Atherectomy of Common Femoral Arterial Lesions. Ann Vasc Surg. 2026. PMID: 42562221. doi:10.1016/j.avsg.2026.07.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。